[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 5, Issue 1 (1-2014) ::
Caspian J Intern Med 2014, 5(1): 46-48 Back to browse issues page
Alendronate-Related Femoral Fracture in a premenopausal glucocorticoid treated patient
Maryam Mobini
MD Department of Rheumatology, Mazandaran University of Medical Sciences, Sari, Iran. , mmobini50@yahoo.com
Abstract:   (22870 Views)
Abstract Background: Alendronate is a bisphosphonate that is approved to reduce bone loss in glucocorticoid treated patients. In this paper, we present a case of femoral fracture following the use of Alendronate. Case presentation: A- 46 year old woman who was a known case of hemolytic anemia has been treated by prednisolone (with different doses from 7.5 to 75 mg/day), calcium-D 500 mg/day and alendronate 70 mg/week for 3 years. Despite improvement of bone density, she experienced a low truama femoral shaft fracture. Conclusion: This case shows a rare complication of treatment by alendronate. It may be needed to evaluate patients with long term usage of bisphosphonates for cortical thickness.
Keywords: Alendronate, Bisphosphonate, Fracture, Prednisolon, Hemolytic anemia
Full-Text [PDF 111 kb]   (1633 Downloads)    
Type of Study: Original Article | Subject: Infectious Diseases
Received: 2013/12/21 | Accepted: 2013/12/21 | Published: 2013/12/21
Send email to the article author

Add your comments about this article
Your username or Email:

Write the security code in the box >


XML     Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Mobini M. Alendronate-Related Femoral Fracture in a premenopausal glucocorticoid treated patient . Caspian J Intern Med. 2014; 5 (1) :46-48
URL: http://caspjim.com/article-1-43-en.html


Volume 5, Issue 1 (1-2014) Back to browse issues page
Caspian Journal of Internal Medicine
Persian site map - English site map - Created in 0.05 seconds with 31 queries by YEKTAWEB 3708